Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, January 24, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, January 23, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, January 22, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sean Lavin Downgraded (ABT) to Hold on, Jan 22nd, 2018
Sean Lavin of BTIG, Downgraded "Abbott Laboratories" (ABT) to Hold on, Jan 22nd, 2018.
Sean has made no other calls on ABT in the last 4 months.
There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 1 agrees with Sean's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017
These are the ratings of the 5 analyists that currently disagree with Sean
- Vijay Kumar of "Evercore ISI Group" Initiated at Buy and Held Target at $64 on, Wednesday, January 3rd, 2018
- David Lewis of "Morgan Stanley" Upgraded from Hold to Buy on, Tuesday, January 2nd, 2018
- Michael Weinstein of "JP Morgan" Upgraded from Hold to Buy on, Tuesday, January 2nd, 2018
- Joanne Wuensch of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $65 on, Tuesday, December 12th, 2017
- Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $64 on, Thursday, October 19th, 2017
